换一批
换一批Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
作者：
Lindsay B,Kilburn [1]
;
Dong-Anh,Khuong-Quang [2]
;
Jordan R,Hansford [3]
;
Daniel,Landi [4]
;
Jasper,van der Lugt [5]
;
Sarah E S,Leary [6]
;
Pablo Hernáiz,Driever [7]
;
Simon,Bailey [8]
;
Sébastien,Perreault [9]
;
Geoffrey,McCowage [10]
;
Angela J,Waanders [11]
;
David S,Ziegler [12]
;
Olaf,Witt [13]
;
Patricia A,Baxter [14]
;
Hyoung Jin,Kang [15]
;
Timothy E,Hassall [16]
;
Jung Woo,Han [17]
;
Darren,Hargrave [18]
;
Andrea T,Franson [19]
;
Michal,Yalon Oren [20]
;
Helen,Toledano [21]
;
Valérie,Larouche [22]
;
Cassie,Kline [23]
;
Mohamed S,Abdelbaki [24]
;
Nada,Jabado [25]
;
Nicholas G,Gottardo [26]
;
Nicolas U,Gerber [27]
;
Nicholas S,Whipple [28]
;
Devorah,Segal [29]
;
Susan N,Chi [30]
;
Liat,Oren [31]
;
Enrica E K,Tan [32]
;
Sabine,Mueller [33]
;
Izzy,Cornelio [34]
;
Lisa,McLeod [35]
;
Xin,Zhao [36]
;
Ashley,Walter [37]
;
Daniel,Da Costa [38]
;
Peter,Manley [39]
;
Samuel C,Blackman [40]
;
Roger J,Packer [41]
;
Karsten,Nysom [41]
作者单位：
Children's National Hospital, Washington, DC, USA. lkilburn@childrensnational.org.
[1]
Children's Cancer Centre, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
[2]
Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
[3]
South Australia Health and Medical Research Institute, Adelaide, Australia; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.
[4]
Duke University, Durham, NC, USA.
[5]
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
[6]
Cancer and Blood Disorders Center, Seattle Children's, Seattle, WA, USA.
[7]
Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, German HIT-LOGGIC-Registry for LGG in Children and Adolescents, Berlin, Germany.
[8]
Great North Children's Hospital and Newcastle University Centre for Cancer, Newcastle-upon-Tyne, UK.
[9]
CHU Sainte-Justine, Université de Montréal, Montréal, Quebec, Canada.
[10]
Sydney Children's Hospitals Network, Westmead, New South Wales, Australia.
[11]
Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA.
[12]
Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
[13]
Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
[14]
School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
[15]
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
[16]
Clinical Cooperation Unit, Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[17]
Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
[18]
German Cancer Consortium (DKTK), Heidelberg, Germany.
[19]
National Center for Tumor Diseases (NCT), Heidelberg, Germany.
[20]
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
[21]
Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea.
[22]
Children's Health Queensland Hospital and Health Service, South Brisbane, QLD, Australia.
[23]
Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.
[24]
UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.
[25]
C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, MI, USA.
[26]
Pediatric Hemato-Oncology, Sheba Medical Center, Ramat Gan, Israel.
[27]
Department of Pediatric Oncology, Schneider Children's Medical Center, Petach Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
[28]
Department of Pediatrics, Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
[29]
Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
[30]
Division of Hematology and Oncology, Department of Pediatrics, School of Medicine, Washington University, St. Louis, MO, USA.
[31]
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH), Montreal, Quebec, Canada.
[32]
Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Australia, and Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
[33]
Department of Oncology, University Children's Hospital, Zurich, Switzerland.
[34]
Primary Children's Hospital and University of Utah, Salt Lake City, UT, USA.
[35]
NYU Langone Health, New York, NY, USA.
[36]
Pediatric Neuro-Oncology, Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
[37]
Department of Hematology & Oncology, Rambam Healthcare Campus, Haifa, Israel.
[38]
Haematology/Oncology Service, KK Women's and Children's Hospital, Singapore, Singapore.
[39]
Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
[40]
Day One Biopharmaceuticals, Brisbane, CA, USA.
[41]
Division of Neurology, Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
[42]
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
[43]
DOI
10.1038/s41591-024-02910-1
PMID
38467878
发布时间
2024-05-24
- 浏览0
Nature medicine
Nature medicine
1500页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
